| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $277.0M | $217.5M | $207.6M |
| YoY Revenue Growth % | +27.4% | +4.7% | — |
| Gross Profit | $100.8M | $77.1M | — |
| Gross Margin % | 36.4% | 35.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $46.8M | $32.4M | $22.9M |
| Operating Margin % | 16.9% | 14.9% | 11.0% |
| Net Income (GAAP) | $38.9M | -$150.3M | $14.5M |
| EBITDA (Normalized) | $84.1M | $67.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $73.0M | $38.2M | $100.0M |
| Capital Expenditures (CapEx) | $46.7M | $43.5M | — |
| Free Cash Flow (FCF) | $26.3M | -$5.4M | $100.0M |
| FCF Margin % | 9.5% | -2.5% | 48.2% |
| Return on Invested Capital (ROIC %) | 10.3% | 8.2% | — |
| Cash & Short-Term Equivalents | $5.1M | $17.8M | — |
| Total Debt (Short + Long Term) | $11.7M | $4.8M | — |
| Total Stockholders' Equity | $351.2M | $326.5M | — |